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Degradomics: Proteome-wide identiﬁcation 
of protease substrates
Ÿ Cleavage a of substrate by a protease of interest generates new N and C termi not present in the control 
samples
Ÿ Challenge: relatively small number of terminal peptides is lost in the majority of internal tryptic peptides
 → high sample complexity
Ÿ „TAILS“ approach: Label and enrich terminal peptides (including protease generated N termini) for 
identiﬁcation
Background
Ÿ Proteolysis is an essential, irreversible posttranslational protein modiﬁcation, involved in the regulation of 
many cellular processes.
Ÿ Over 800 different proteases are encoded by the Arabidopsis thaliana genome, illustrating the importance 
of these enzymes in higher plants. However, for most of these proteases no in vivo substrates have been 
identiﬁed yet and their physiological functions still remain unclear.
Ÿ The amino acid sequence of CLAP1 shows some atypical features such as its unusual high amount of 
cysteine residues that might indicate a regulation by stress-induced redox changes in the cell and a 
predicted putative DNA-binding sequence, implying some yet unknown DNA interaction potentially 
involved in the localization or activity regulation of the protease. However, no physiological substrates 
have been described for CLAP1 yet and no CLAP1 knock-out mutant is available that could provide a clue 
about the physiological function of this protease.
„N-TAILS“ for CLAP1 substrate identiﬁcation
Protein extracts are incubated with 
recombinant wildtype and ac ve-site 
mutant CLAP1. Proteoly c ac vity 
generates protein N termini that are 
not present in the control samples.
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Prepare proein extract 
(e.g.total protein, 
chloroplast or membrane 
extract)
Primary amines of N termini 
and lysines are labeled and 
blocked (e.g. stable isotope 
dimethyl labeling or TMT 
labeling).
Samples are mixed and digested with trypsin. The 
labeled N termini of the proteins remain blocked, while 
the newly generated internal tryp c pep des carry 
unblocked N termini with free primary amines.
A hyperbranched polyglycerol and aldehyde (HPG) polymer is 
added to the sample to react with the primary amines at the 
free N termini of tryp c pep des. The blocked original 
protein N termini do not bind to the polymer and can be 
separated by ﬁltra on. 
LC-MS/MS
Bioinforma cs
Recombinant expression and puriﬁcation of CLAP1
Conclusion and Outlook
Ÿ Wildtype CLAP1 and a CLAP1 active-site mutant were successfully 
expressed
Ÿ Recombinant CLAP1 wildtype is active at acidic pH (~4.0) and showed 
sensitivity to the speciﬁc aspartic protease inhibitor pepstatin 
Ÿ No proteolytic activity of CLAP1 active site mutant (control sample) 
Ÿ Proteomics-based identiﬁcation of CLAP1 substrates on relevant 
Arabidopsis thaliana extracts is in preparation
Arabidopsis Thaliana
Evaluation of „N-TAILS“ experiments
Evaluation of TAILS LC-MS/MS data requires at least 2 Max-Quant database searches and some 
considerations:
Ÿ Digestion mode: Semispeciﬁc free N terminus
st
Ÿ 1  search: Quantiﬁcation set to labeled N termini and labeled lysines 
-> Identify original and protease generated protein N termini 
nd
Ÿ 2  search: Quantiﬁcation set to labeled lysines only. Variable modiﬁcations 
(acetylation, Glu-> pyro Glu, Gln-> pyro Glu) on N termini 
-  > Identify N-terminal peptide modiﬁcations that are also enriched by „N-TAILS“
Additional considerations when using stable isotope dimethyl labeling:
rd
Ÿ 3  search: No quantiﬁcation, variable monomethylation on N termini and lysines
-> Control of labeling efﬁciency
Ÿ Select Arg-C (missed cleavage > 2 ) as digestion protease since trypsin proteolysis at dimethylated 
lysins is very rare
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1. Transformation of E. coli 
with recombinant vectors 
containing the CLAP1 
wildtype and active site 
mutant sequence  
2. Expression of CLAP1 
as inclusion bodies
3. Extraction of CLAP1 
inclusion bodies and 
refolding by dialysis
 
Refolding yields correctly 
folded CLAP1 as well as 
misfolded, denatured  and 
aggregated CLAP1. 
5. Differently folded CLAP1 forms are seperated by 
anion exchange chromatography due to their different 
surface charge
6. We expressed and puriﬁed two 
independant batches of CLAP1 
under slightly different refolding 
conditions. In both experiments a 
signiﬁcant protease activity against 
a ﬂuorogenic protease substrate 
(MCA-Lys-Lys-Pro-Ala-Glu-Phe-
Phe-Ala-Leu-Lys-DNP) was 
observed in all relevant IEX 
fractions.The active site mutant 
showed no signiﬁcant protease 
activity in the corresponding IEX 
fractions.
7. We observed that the fractions 
that elute early from IEX are much 
more sensitive to inhibition by the 
speciﬁc aspartic protease inhibitor 
pepstatin compared to the later 
eluting fractions. This indicates that 
IEX leads to a separation of 
differently folded CLAP1 forms with 
different activity / inhibition proﬁles.
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4. In the ﬁrst puriﬁcation step, aggregates are separated 
from monomers by size exclusion chromatography (SEC)
